KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Calumet (CLMT) EBITDA (2023 - 2025)

Calumet (CLMT) has disclosed EBITDA for 3 consecutive years, with -$64.5 million as the latest value for Q4 2025.

  • Quarterly EBITDA fell 384.14% to -$64.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108.7 million through Dec 2025, up 1241.98% year-over-year, with the annual reading at $108.7 million for FY2025, 1241.98% up from the prior year.
  • EBITDA for Q4 2025 was -$64.5 million at Calumet, down from $322.9 million in the prior quarter.
  • The five-year high for EBITDA was $322.9 million in Q3 2025, with the low at -$101.0 million in Q2 2025.
  • Average EBITDA over 3 years is $31.0 million, with a median of $6.2 million recorded in 2024.
  • Peak annual rise in EBITDA hit 665.5% in 2025, while the deepest fall reached 1729.03% in 2025.
  • Over 3 years, EBITDA stood at -$13.9 million in 2023, then soared by 263.31% to $22.7 million in 2024, then plummeted by 384.14% to -$64.5 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$64.5 million, $322.9 million, and -$101.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.